Chmfl-abl-053

Author: kigv

August undefined, 2024

WebOct 1, 2024 · A novel BCR-ABL inhibitor CHMFL-ABL-053 (here referred to as 053) was developed by our group. 15 053 has better selectivity than imatinib, nilotinib and dasatinib with less inhibition to DDR1 (IC50: 292 nM) and DDR2 (IC50: 457 nM), and without any inhibition to c-Kit (IC 50: > 10 μM), which is the common off-target for the clinically used … WebJan 13, 2024 · CHMFL-ABL-053. CAS No. : 1808287-83-3. Biological Activity：CHMFL-ABL-053 (Compound 18a) is a potent, selective, and orally available BCR-ABL, SRC …

CHMFL-ABL-053

WebCHMFL-ABL-053 (053), a hydrophobic drug candidate discovered by our group, was employed as a model drug to demonstrate the performance of [email protected] delivery … WebCHMFL-ABL-053 (Compound 18a) is a potent, selective, and orally available BCR-ABL, SRC and p38 kinase inhibitor with IC50 values of 70, 90 and 62 nM against ABL1, SRC … curry college academic success

CHMFL-ABL-053 CAS:1808287-83-3 BCR-ABL inhibitor High …

http://shiji.cnreagent.com/s/sv40807.html WebCHMFL-ABL-053 (Compound 18a) is a potent, selective, and orally available BCR-ABL, SRC and p38 kinase inhibitor with IC 50 values of 70, 90 and 62 nM against ABL1, SRC and p38, respectively. HY-146697 IHMT-TRK-284. Inhibitor; WebSep 5, 2024 · By conjugating CHMFL-ABL-053 to an amphiphilic polymer and subsequent self-assembling into a nanoparticle (NP) with a high loading, an ultra-long circulating … charter netgear router

CAS 1808287-83-3 CHMFL-ABL-053 - BOC Sciences

CHMFL-ABL-053 BCR-ABL inhibitor Cas# 1808287-83-3 - GlpBio

WebCHMFL-ABL-053 exhibited an IC50 of 70 nM against ABL1 kinase, inhibited p38α (IC50: 62 nM) and SRC kinase (IC50: 90 nM) by Invitrogen Select Screen biochemical assay. CHMFL-ABL-053 showed less potent to DDR1 (IC50: 292 nM) and DDR2 (IC50: 457 nM). CHMFL-ABL-053 did not exhibit apparent potency against c-KIT kinase (IC50: over 10000 nM). [1] curry college health servicesWebFigure 8. Compound 18a’s antitumor efficacy in the K562 xenograft model. Female nu/nu mice bearing an established control group and K562 tumor xenografts were treated with 18a at 25.0, 50.0 mg/kg/d, or vehicle. Daily oral administration was initiated when K562 tumors had reached a size of 200 to 400 mm3. Each group contained 5 animals. Data = mean ± … curry college college in milton massachusetts

"WebCHMFL-ABL-053 is a potent, selective and orally bioavailable BCR-ABL/SRC/p38 kinase inhibitor for Chronic Myeloid Leukemia. Through significant suppression of the BCR-ABL auto-phosphorylation (EC50 about 100 nM) and downstream mediators such as STAT5, Crkl and ERK's phosphorylation, CHMFL-ABL-053 inhibited the proliferation of CML cell lines ... " - Chmfl-abl-053

Chmfl-abl-053

WebAug 24, 2024 · An ultra-long circulating nanomaterial has been developed by researchers through the conjugation of CHMFL-ABL-053 to an amphiphilic polymer and subsequent … WebFeb 27, 2024 · CHMFL-ABL-053 (053), a hydrophobic drug candidate discovered by our group, was employed as a model drug to demonstrate the performance of NC@Lipo delivery system.

Did you know?

WebHere we report a novel type II BCR-ABL kinase inhibitor, CHMFL-ABL-039, which not only displayed great potency (IC 50: 7.9 nM) and selectivity (S score (1) = 0.02) against native ABL kinase among other kinases in the kinome, but also exhibited great potency (IC 50: 27.9 nM) and selectivity against Imatinib-resistant V299L mutant among other ... WebAug 24, 2024 · And the BCR-ABL inhibitor CHMFL-ABL-053 had a better selectivity to the target of BCR-ABL over other protein kinases. However, like all of this class of inhibitors, it must be treated orally every day due to its short half-life, which would not only increase the economic burden of patients, but also lead to cumulative toxicities.

WebAMS-DTL-23053/12-504-C Mil Spec Equivalent M23053/12-504-C Mil Spec 4:1 Heat Shrink 1/4 inch Clear 4 ft Stick WebCHMFL-ABL-053 Name： CHMFL-ABL-053; CAS Number: 1808287-83-3; MF: C 28 H 26 F 3 N 7 O 2; MW: 549.547; Density: 1.4±0.1 g/cm3; Boiling Point: N/A; Melting Point: N/A; Flash Point: N/A; Check Price. Check Suppliers. CHMFL-BMX-078 Name： CHMFL-BMX-078; CAS Number: ...

WebChmfl-abl-053 C28H26F3N7O2 CID 122634050 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, … WebJul 7, 2016 · CHMFL-074 is a highly potent and selective BCR-ABL/PDGFR inhibitor. Aiming to develop a highly selective BCR-ABL inhibitor, starting from the Imatinib core pharmacophore, we performed a focused medicinal library design and screening which led to the discovery of CHMFL-074 (Chemical Structure shown in Figure Figure1A). …

WebCHMFL-ABL-053 is a potent, selective and orally bioavailable BCR-ABL/SRC/p38 kinase inhibitor for Chronic Myeloid Leukemia. Through significant suppression of the BCR-ABL …

WebName: CHMFL-ABL-053 CAS#: 1808287-83-3 Chemical Formula: C28H26F3N7O2 Exact Mass: 549.21 Molecular Weight: 549.5582 Elemental Analysis: C, 61.20; H, 4.77; F, 10.37; N, 17.84; O, 5.82 Price and Availability Technical data Solubility and formulation Calculators References Synonym: CHMFL-ABL-053; CHMFL-ABL053; CHMFL-ABL 053. curry college dean\u0027s listWebNov 16, 2024 · Nov 15, 2024. #9. A guy at work bought a new 07 Silverado with a 5.3 & DOD. His maintenance style could be called casual indifference, he takes the truck to … curry college costWebO uso de sistemas de ar condicionado solar vem crescendo em paises como Estados Unidos, China e membros da Uniao Europeia. Entretanto, a despeito dos altos niveis de insolacao e do aumento do uso de sistemas convencionais no pais, tal tecnologia ainda se encontra restrita ao ambiente academico. curry college information deskWebBOC Sciences is the world-leading provider of special chemicals. We offer qualified product CHMFL-ABL-053 (1808287-83-3), please inquire us for CHMFL-ABL-053 (1808287-83-3). curry college graduate programsWebMar 20, 2024 · Through exploration of the non-highly conserved allosteric hydrophobic pocket generated by DFG-out shifting in the inactive conformation, we discovered a highly selective type II PDGFRα kinase inhibitor 15i (CHMFL-PDGFRα-159), which exhibited strong potency against purified PDGFRα (IC50: 132 nM) but not structurally similar … curry college employment opportunitiesWebProduct Description CHMFL-ABL-053 is a potent and orally available inhibitor of BCR-ABL (IC50 = 70nM) without inhibitory activity against c-KIT kinase that is a common target of BCR-ABL inhibitors currently used. charter netgear wireless routerWebBcr-Abl Src p38 MAPK Cancer; CHMFL-ABL-053 (Compound 18a) is a potent, selective, and orally available BCR-ABL, SRC and p38 kinase inhibitor with IC 50 values of 70, 90 and 62 nM against ABL1, SRC and p38, respectively. HY-14979A. ML786 dihydrochloride. Raf Bcr-Abl Discoidin Domain Receptor VEGFR RET Ephrin Receptor curry college ice hockey